Abstract
To date, Transarterial Chemoembolization (TACE) and Arterial Infusion Chemotherapy are deemed as two major methods of interventional therapy being equipped with the advantages of small trauma, easy operation, good prognosis and swift operation speed. It is indicated by emerging preclinical and clinical data that the vascular intervention therapy can induce a peripheral anti-tumor immune response, which will impact the immune microenvironment, increase the expression of PD-L1 in tumor cells, and augment the effects of immune checkpoint inhibitors as well.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
